Clinical trial
A Single-Centre, Open-label Study Testing the Safety and Performance of the Glyconics-SX System in Individuals With or Without Type 2 Diabetes
NCT05476016 is registered in ClinicalTrials.gov with Glyconics Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-Centre, Open-label Study Testing the Safety and Performance of the Glyconics-SX System in Individuals With or Without Type 2 Diabetes
- Lead sponsor
- Glyconics Ltd
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 29, 2022
- Completion date
- December 8, 2022
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.